Holen Sie sich die Stockscreener-App
0.2218
3.57%
-0.0082
Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
14.53%
9.2637
|
8.0888 | 8.5771 | 9.4172 | 9.4102 |
| Cost Of Revenue |
15.73%
6.837
|
5.9078 | 5.5483 | 6.3436 | 5.9874 |
| Gross Profit |
11.27%
2.4267
|
2.181 | 3.0288 | 3.0735 | 3.4229 |
| Research and Development |
58.32%
0.0132
|
0.0317 | 0.0735 | - | - |
| Depreciation and Amortization |
0.078
|
- | - | - | - |
| Operating Income/Loss |
15.57%
-1.6129
|
-1.3956 | -1.79 | -1.0866 | -2.0547 |
| Nonoperating Income/Loss |
67.83%
0.0488
|
0.1517 | 0.0575 | 0.0654 | 0.0747 |
| Income/Loss From Continuing Operations Before Tax |
25.74%
-1.564
|
-1.2439 | -1.7326 | -1.0213 | -1.98 |
| Income Tax Expense/Benefit |
-
|
- | 0.4084 | -0.1374 | -0.2092 |
Net Income/Loss
|
25.74%
-1.564
|
-1.2439 | -2.1409 | -0.8838 | -1.7708 |
| Basic Average Shares |
72.17%
1.3653
|
4.9059 | - | 4.5559 | 4.4961 |
| Basic Earnings Per Share |
360.00%
-1.15
|
-0.25 | - | -0.19 | -0.39 |
4.51%
5.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):